Panxia Wang
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiac Fibrosis and Remodeling
Papers in
-
- Signaling Pathways in Disease 6
- Wnt/β-catenin signaling in development and cancer 3
-
- Chemotherapy-induced cardiotoxicity and mitigation 9
- Cardiac Fibrosis and Remodeling 5
- Co-authors
- Jing Lü (24 shared papers)Peiqing Liu (21 shared papers)Yuehuai Hu (13 shared papers)Peiqing Liu (5 shared papers)Junjian Wang (8 shared papers)Jingyan Li (9 shared papers)Zhen Guo (8 shared papers)Duanping Sun (3 shared papers)
- Journals
- Acta Pharmacologica Sinica (8 papers)Frontiers in Pharmacology (5 papers)Acta Pharmaceutica Sinica B (4 papers)Molecular and Cellular Endocrinology (3 papers)Pharmacological Research (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Panxia Wang
37 papers receiving 939 citations
Peers
Comparison fields: 5 of 84
- Geriatrics and Gerontology 82
- Cardiology and Cardiovascular Medicine 254
- Cancer Research 147
- Molecular Biology 582
- Physiology 36
Countries citing papers authored by Panxia Wang
This map shows the geographic impact of Panxia Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Panxia Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Panxia Wang more than expected).
Fields of papers citing papers by Panxia Wang
This network shows the impact of papers produced by Panxia Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Panxia Wang. The network helps show where Panxia Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Panxia Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 86 | |
| 2 | 2019 | 81 | |
| 3 | 2020 | 78 | |
| 4 | 2018 | 45 | |
| 5 | 2020 | 44 | |
| 6 | 2020 | 40 | |
| 7 | 2017 | 38 | |
| 8 | 2020 | 35 | |
| 9 | 2018 | 35 | |
| 10 | 2019 | 33 | |
| 11 | 2018 | 32 | |
| 12 | 2019 | 31 | |
| 13 | 2020 | 26 | |
| 14 | 2018 | 26 | |
| 15 | 2023 | 26 | |
| 16 | 2020 | 24 | |
| 17 | 2020 | 24 | |
| 18 | 2020 | 23 | |
| 19 | 2021 | 22 | |
| 20 | 2018 | 21 |
About Panxia Wang
Panxia Wang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Oncology, Epidemiology and Geriatrics and Gerontology, having authored 40 papers that have together received 943 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (9 papers), Signaling Pathways in Disease (6 papers), Autophagy in Disease and Therapy (6 papers), Sirtuins and Resveratrol in Medicine (5 papers), Cardiac Fibrosis and Remodeling (5 papers), PARP inhibition in cancer therapy (5 papers), Peptidase Inhibition and Analysis (4 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). The work is most often cited by research in Geriatrics and Gerontology (82 citations), Cardiology and Cardiovascular Medicine (254 citations), Cancer Research (147 citations), Molecular Biology (582 citations) and Physiology (36 citations). Panxia Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jing Lü, Peiqing Liu, Yuehuai Hu, Peiqing Liu, Junjian Wang, Jingyan Li, Zhen Guo, Duanping Sun, Zhuoming Li and Jiantao Ye. Their work appears in journals such as Acta Pharmacologica Sinica, Frontiers in Pharmacology, Acta Pharmaceutica Sinica B, Molecular and Cellular Endocrinology and Pharmacological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.